Previous close | 4.2100 |
Open | 4.2960 |
Bid | 4.2000 x 1400 |
Ask | 4.2700 x 1000 |
Day's range | 4.2000 - 4.2960 |
52-week range | 3.6700 - 5.7700 |
Volume | |
Avg. volume | 17,887 |
Market cap | 68.632M |
Beta (5Y monthly) | 1.29 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings date | 26 July 2023 - 31 July 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Potential Ultralife Corporation ( NASDAQ:ULBI ) shareholders may wish to note that the Independent Chairman, Bradford...
NEWARK, N.Y., April 27, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported breakeven operating income and adjusted EBITDA of $1.2 million on revenue of $31.9 million for the first quarter ended March 31, 2023. The operating results for the first quarter of 2023 were negatively impacted by the cybersecurity attack announced by the Company on March 2, 2023. For the first quarter of 2022, the Company reported an operating loss of $0.3 million and adjusted EBITDA of $1.1 million
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2023 before the market opens on Thursday, April 27, 2023. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on April 27, 2023. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conf
Investors who take an interest in Ultralife Corporation ( NASDAQ:ULBI ) should definitely note that the Independent...
Ultralife ( NASDAQ:ULBI ) Full Year 2022 Results Key Financial Results Revenue: US$131.8m (up 34% from FY 2021). Net...
NEWARK, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating profit of $0.2 million and adjusted EBITDA of $2.0 million on revenue of $36.1 million for the fourth quarter ended December 31, 2022. The operating results for the fourth quarter of 2022 include a one-time charge of $0.8 million for 2023 severance costs associated with the Company’s former President & CEO, who, as announced on November 22, 2022, is no longer with the Company. For the fourth
For many, the main point of investing is to generate higher returns than the overall market. But in any portfolio...
NEWARK, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) announced today the addition of Janie Goddard as Director of the Company. Chairman Bradford Whitmore said, “We are pleased to welcome Janie to our Board of Directors and look forward to leveraging her extensive business career. Janie is an experienced, results-driven executive who brings a strong track record of P&L leadership within global companies and a background in commercial execution, strategic marketing,
NEWARK, N.Y., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2022 before the market opens on Thursday, March 2, 2023. We are reporting our quarterly results later than our customary reporting practice due to illnesses experienced by some members of our Accounting/Finance Team causing delays in the year-end closing and audit. Ultralife’s Management will also host an investor conference call and simult
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation (“Ultralife” or the “Company”) (NASDAQ: ULBI) has appointed Michael E. Manna as the Company’s President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addi
NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported an operating loss of $0.6 million and adjusted EBITDA of $1.3 million on revenue of $33.2 million for the third quarter ended September 30, 2022. For the third quarter of 2021, the Company reported an operating loss of $0.8 million and adjusted EBITDA of $0.3 million on revenue of $21.8 million. “For the third quarter, government/defense revenue doubled year-over-year reflecting higher demand from our c
NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $5.5 million to supply its vehicle communications systems to a global prime defense contractor for the U.S. Army. Ultralife’s vehicle communications platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence and be completed in 2023. “We are delighted to rec
NEWARK, N.Y., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2022, before the market opens on Thursday, October 27, 2022. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on October 27, 2022. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultrali
NEWARK, N.Y., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received a contract valued at approximately $7.5 million to supply its integrated system of A-320 amplifiers and A-320HVA radio vehicle mounts to a major international defense contractor for an ongoing government/defense modernization program. Deliveries are expected to commence in the fourth quarter of 2022 and continue through the first half of 2023. “This contract further demonstrates our success in exec
Many investors define successful investing as beating the market average over the long term. But its virtually certain...
Potential Ultralife Corporation ( NASDAQ:ULBI ) shareholders may wish to note that the Independent Chairman, Bradford...
NEWARK, N.Y., July 28, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.8 million and Adjusted EBITDA of $2.2 million on revenue of $32.1 million for the second quarter ended June 30, 2022. For the second quarter of 2021, the Company reported operating income of $1.1 million and Adjusted EBITDA of $2.2 million on revenue of $26.8 million. “Driven by the Excell acquisition and strong shipments to core commercial end-markets, for the second quarter we d
NEWARK, N.Y., July 26, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $4.6 million to supply its Vehicle Amplifier-Adaptors (“VAA”) to a global prime defense contractor. Ultralife’s VAA platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence in 2022. “We are delighted to receive this order that further attests to the effect
NEWARK, N.Y., July 14, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2022, before the market opens on Thursday, July 28, 2022. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on July 28, 2022. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A
Investors who take an interest in Ultralife Corporation ( NASDAQ:ULBI ) should definitely note that the Independent...